Concepedia

Institution (Company)

ReveraGen BioPharma (United States)

HomepageROR

Also Known As

ReveraGen BioPharma (United States)

79

Publications

6.1K

Citations

5

Authors

77

Concepts

About

ReveraGen BioPharma (United States) is a company institution in Rockville, United States known for medicine, immunology, and inflammation.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

12

40

1.4K

2

Natural Sciences

2

4

177

3

Health Sciences

1

2

86

4

Applied Physiology

1

2

86

5

Biochemistry

1

3

159

ReveraGen BioPharma (United States)

×

79

Publications

6.1K

Citations

YearCitations

VBP15, a novel anti‐inflammatory and membrane‐stabilizer, improves muscular dystrophy without side effects

Christopher R. Heier, Jesse M. Damsker, Qing Yu,

EMBO Molecular Medicine

2013

188

Efficacy and Safety of Vamorolone vs Placebo and Prednisone Among Boys With Duchenne Muscular Dystrophy

Michela Guglieri, Paula R. Clemens, Seth J. Perlman,

JAMA Neurology

2022

107

Phase IIa trial in Duchenne muscular dystrophy shows vamorolone is a first-in-class dissociative steroidal anti-inflammatory drug

Laurie S. Conklin, Jesse M. Damsker, Eric P. Hoffman,

Pharmacological Research

2018

93

Efficacy and Safety of Vamorolone in Duchenne Muscular Dystrophy

Jean K. Mah, Paula R. Clemens, Michela Guglieri,

JAMA Network Open

2022

79

Efficacy and safety of vamorolone in Duchenne muscular dystrophy: An 18-month interim analysis of a non-randomized open-label extension study

Edward C. Smith, Laurie S. Conklin, Eric P. Hoffman,

PLoS Medicine

2020

78

Vamorolone targets dual nuclear receptors to treat inflammation and dystrophic cardiomyopathy

Christopher R. Heier, Qing Yu, Alyson A. Fiorillo,

Life Science Alliance

2019

77

Phase 1 trial of vamorolone, a first-in-class steroid, shows improvements in side effects via biomarkers bridged to clinical outcomes

Eric P. Hoffman, Valerie Riddle, Maxime A. Siegler,

Steroids

2018

72

VBP15: Preclinical characterization of a novel anti-inflammatory delta 9,11 steroid

Erica Reeves, Eric P. Hoffman, Kanneboyina Nagaraju,

Bioorganic & Medicinal Chemistry

2013

68

Identification of Pathway-Specific Serum Biomarkers of Response to Glucocorticoid and Infliximab Treatment in Children with Inflammatory Bowel Disease

Christopher R. Heier, Alyson A. Fiorillo, Ellen Chaisson,

Clinical and Translational Gastroenterology

2016

65

Large-Scale Ex Vivo Generation of Human Red Blood Cells from Cord Blood CD34+ Cells

Yu Zhang, Chen Wang, Lan Wang,

Stem Cells Translational Medicine

2017

57

Page 1